The phrase "a decrease in drugs" is correct and usable in written English.
It can be used when discussing a reduction in the quantity or availability of drugs, whether in a medical, social, or legal context.
Example: "The new policy has led to a significant decrease in drugs available on the streets."
Alternatives: "a reduction in drugs" or "a decline in drugs".
Because of these, the recent trend indicating a decrease in drug approvals is being corrected.
Chemical incompatibilities can lead to a decrease in drug delivery, drug degradation, and/or production of toxic products.
The metformin formulation did have a decrease in drug release profile at 40% ethanol medium that was caused by the decrease in solubility of metformin in alcohol.
Elevation of [Na]o may reverse the blocking action of local anesthetic-class drugs by an increase in single-channel current amplitude or by a decrease in drug association rate with the sodium channel.
Vazquez said stepped-up interdiction measures has coincided with a decrease in drug purity, leaving addicts scrambling, sometimes by violent means, to obtain their chemical of choice.
In addition, the balloon effect -- a decrease in drug activity leading to an increase in other regions of the world -- seems to be affecting certain regions like West Africa.
Another example of how the "perfect victim" paradigm blinds us to the injustices faced by those who don't fit its construct is our willful ignorance of the most severe human rights violation in the United States today -- the mass incarceration of poor black and Latino men and youth due to the 'war on drugs,' a failed policy that has not led a decrease in drug use or availability.
Our theoretical analyses, with a transmission model that includes different levels of immunity, demonstrate that an increase in transmission beyond a threshold can lead to a decrease in drug resistance, as previously shown [1], but that a second threshold may occur and lead to the re-establishment of drug resistance.
For anthracyclines in MDR cells, it has been reported that in addition to a decrease in drug accumulation, the intracellular distribution of the drug is rearranged in human myeloma [44], myeloid [45], lung tumor cells [46], ovarian carcinoma cells [47], and epidermoid carcinoma cells [48].
However, these strategies may not lower overall costs if accompanied by a decrease in drug adherence [ 6, 7].
